跳到正文
原文
Endpoints News 生物医药· Ayisha Sharma·· 2026-10-16AI 评分21

Estuary Biotherapeutics 携 1.03 亿美元启动肾脏疾病基因疗法开发

Estuary debuts with $103M to develop kidney disease gene therapies

AI 导读

Estuary Biotherapeutics 周五携 1.03 亿美元资金亮相,用于推进两个临床前基因疗法候选药物,以开发肾脏疾病基因疗法。

正文

Es­tu­ary Bio­ther­a­peu­tics raised the cur­tain on Fri­day with $103 mil­lion to sup­port the ad­vance­ment of two pre­clin­i­cal gene ther­a­py can­di­dates for the most com­mon type …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news